TY - JOUR
T1 - Italian practical clinical guidelines on cholangiocarcinoma
T2 - Part II, Treatment
AU - Working Group
AU - Alvaro, Domenico
AU - Hassan, Cesare
AU - Cardinale, Vincenzo
AU - Carpino, Guido
AU - Fabris, Luca
AU - Gringeri, Enrico
AU - Granata, Vincenza
AU - Mutignani, Massimiliano
AU - Morement, Helen
AU - Giuliante, Felice
AU - Guglielmi, Alfredo
AU - Ridola, Lorenzo
AU - Tonini, Giuseppe
AU - Marzioni, Marco
AU - Grazi, Gianluca
AU - Guido, Maria
AU - Di Giulio, Emilio
AU - Pantano, Francesco
AU - Venere, Rosanna
AU - Bragazzi, Maria Consiglia
AU - Biancanello, Francesca
AU - Faccioli, Jessica
AU - Giannetti, Aurora
AU - Cintolo, Marcello
AU - Di Giunta, Michela
AU - Gambato, Martina
AU - Lasagni, Alberto
AU - Izzo, Francesco
AU - Avallone, Antonio
AU - Banales, Jesus
AU - Rossi, Massimo
AU - Catalano, Carlo
AU - Laghi, Andrea
AU - D'amati, Giulia
AU - Mancino, Maria Grazia
PY - 2020
Y1 - 2020
N2 - Currently, the only curative treatment for cholangiocarcinoma (CCA) is surgical resection, though this treatment is possible in less than 40% of patients. However, recent improvements in preoperative management have led to a higher number of patients who are candidates for this procedure. For unresectable patients, progress is ongoing in terms of locoregional and chemoradiation treatments and target therapies, especially in the definition of patient selection criteria. This is the second part of the Italian CCA guidelines, dealing with CCA treatment, that have been formulated in accordance with Italian National Institute of Health indications and developed according to the GRADE method and related advancements.
AB - Currently, the only curative treatment for cholangiocarcinoma (CCA) is surgical resection, though this treatment is possible in less than 40% of patients. However, recent improvements in preoperative management have led to a higher number of patients who are candidates for this procedure. For unresectable patients, progress is ongoing in terms of locoregional and chemoradiation treatments and target therapies, especially in the definition of patient selection criteria. This is the second part of the Italian CCA guidelines, dealing with CCA treatment, that have been formulated in accordance with Italian National Institute of Health indications and developed according to the GRADE method and related advancements.
KW - Distal cholangiocarcinoma
KW - Intrahepatic cholangiocarcinoma
KW - Liver transplantation
KW - Locoregional treatments
KW - Perihilar cholangiocarcinoma
KW - Surgery
KW - Target therapies
UR - http://www.scopus.com/inward/record.url?scp=85091232437&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091232437&partnerID=8YFLogxK
U2 - 10.1016/j.dld.2020.08.030
DO - 10.1016/j.dld.2020.08.030
M3 - Review article
AN - SCOPUS:85091232437
SN - 1590-8658
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
ER -